Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease

ISSN： 1083-7450

Source： Pharmaceutical Development and Technology, Vol.18, Iss.2, 2013-04, pp. : 390-400

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mesalamine for Inflammatory Bowel Disease: Recent Reappraisals

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 1, 2008-03 ,pp. : 1-5

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutics in inflammatory bowel disease

By Bernstein Charles N

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 7, 2001-07 ,pp. : 1081-1096

Informa Healthcare

Access to resources Recommend Favorite

Novel approaches to inflammatory bowel disease

By McKaig B. Stack W.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 7, 1998-07 ,pp. : 1099-1113

Informa Healthcare

Access to resources Recommend Favorite

Design and Development of Novel Azo Prodrugs using Various Permutations and Combinations of 5- and 4-Aminosalicylic Acids for Inflammatory Bowel Disease: A Colon-Targeted Approach

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 12, Iss. 5, 2013-10 ,pp. : 328-340

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Treatment Options for Inflammatory Bowel Disease: Targeting α4 Integrin

By Lanzarotto Francesco Carpani Marta Chaudhary Rakesh Ghosh Subrata

Drugs, Vol. 66, Iss. 9, 2006-01 ,pp. : 1179-1189

Adis International

Access to resources Recommend Favorite